Brevan Howard Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$996K	Buy	+37,574	New	+$996K	0.01%	977
2024 Q3	–	Sell	-18,489	Closed	-$980K	–	1413
2024 Q2	$980K	Buy	18,489 +12,013	+186%	+$637K	0.01%	334
2024 Q1	$531K	Buy	+6,476	New	+$531K	﹤0.01%	392